Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

China Grand Pharmaceutical and Healthcare Holdings Ltd

+ Add to Watchlist

512:HK

1.400 HKD 0.0000.00%

As of 03:01:04 ET on 02/27/2015.

Snapshot for China Grand Pharmaceutical and Healthcare Holdings Ltd (512)

Open: 1.410 Day's Range: 1.400 - 1.420 Volume: 1,620,000
Previous Close: 1.400 52wk Range: 1.250 - 1.860 1-Yr Rtn: -4.11%

Stock Chart for 512

No chart data available.
  • 512:HK 1.400
  • 1D
  • 1M
  • 1Y
1.400
Interactive 512 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 512

Current P/E Ratio (ttm) 21.8409
Estimated P/E(-) -
Relative P/E vs. HSI 2.0877
Earnings Per Share (ttm) 0.0641
Est. EPS -
Est. PEG Ratio -
Market Cap (M HKD) 2,746.86
Shares Outstanding (M) 1,962.04
30 Day Average Volume 701,313
Price/Book (mrq) 2.9302
Price/Sale (ttm) 0.9287
Dividend Indicated Gross Yield -%
Cash Dividend (HKD) -
Dividend Ex-Date 05/20/1997
5 Year Dividend Growth -
Next Earnings Announcement 03/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 512

  • Revenue
  • Net Income (M/HKD)
  • Profit Margin (%)

Company Profile & Key Executives for 512

China Grand Pharmaceutical and Healthcare Holdings Limited is an investment holding company, its subsidiaries are principally engaged in the development, manufacture and sale of bulk pharmaceuticals, pharmaceutical intermediates and preparations.

Liu ChengweiChairmanHu BoDeputy Chairman
Shao YanChief Executive OfficerZhang JiExecutive Director
More Company Profile & Key Executives for 512

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil